Melanoma Molecular Maps Projects


Targeted Therapy Database

A systematic collection of the scientific knowledge regarding the development of targeted therapy for melanoma. Since data are gathered in a computationally compatible fashion, the database can be utilized for the identification of prevalent therapeutic hypotheses based on the available evidence and for ranking treatments based on the patient's molecular profile (drug ranking system). In particular the TTD can be queried for the following purposes:

  1. To provide both basic researchers and clinical investigators with an unprecedented synopsis of the available scientific literature on the development of targeted therapy for melanoma;

  2. To obtain summaries of the current evidence on the relationship between each single molecule (or set of molecules) and the efficacy (toxicity) of a given therapeutic agent (or set of therapeutic agents);

  3. To match the patient/cancer molecular profile with the available scientific evidence on the targeted therapy of melanoma, thus developing a drug ranking system for the personalized treatment of melanoma.

Please click on the following links to open the TARGETED THERAPY DATABASE (TTD) and its User's Guide.

The second version of the Targeted Therapy Database (TTD) is now available, with more records on the personalized treatment of melanoma.


"Targeted Therapy Database (TTD): A Model To Match Patient's Molecular Profile With Current Knowledge On Cancer Biology". By: Mocellin S., Shrager J., Scolyer R., Pasquali S., Verdi D., Marincola F.M., Briarava M., Gobbel R., Rossi C., Nitti D.
PLoS One (2010), 5(8):e11965

Search the site

Risk Assessment Tools

TNM Staging System | Total Dermoscopy Score | Thin Melanoma Prognosis |

Melanoma News

Mandibular metastasis of cutaneous melanoma.
Amadeu J, Piazzetta CM, Torres-Pereira CC, Amenábar JM
J Oral Biol Craniofac Res. 2016 Sep-Dec;6(3):250-252.
PMID: 27761393 [Unknown status]

The emerging role of long non-coding RNAs in cutaneous melanoma.
Leucci E, Coe EA, Marine JC, Vance KW
Pigment Cell Melanoma Res. 2016 Sep 8;():.
PMID: 27606977 [PubMed]

Prospective evaluation of prognostic indicators for early recurrence of cutaneous melanoma.
Matheson JA, Te Marvelde L, Mailer S, Speakman D, Spillane J, Henderson MA, Gyorki DE
Melanoma Res. 2016 Oct 6;():.
PMID: 27753732 [PubMed]

Occupational exposure to polychlorinated biphenyls and risk of cutaneous melanoma: a meta-analysis.
Boffetta P, Catalani S, Tomasi C, Pira E, Apostoli P
Eur J Cancer Prev. 2016 Oct 5;():.
PMID: 27749494 [PubMed]

Sentinel Lymph Node Biopsy in Cutaneous Melanoma: Standard and New Technical Procedures and Clinical Advances. A Systematic Review of the Literature.
Tardelli E, Mazzarri S, Rubello D, Gennaro M, Fantechi L, Duce V, Romanini A, Chondrogiannis S, Volterrani D, Colletti PM, Manca G
Clin Nucl Med. 2016 Oct 5;():.
PMID: 27749418 [PubMed]

NCBI's Disclaimer and Copyright notice